These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7196633)
1. [Evaluation of cytomorphological parameters during hormonal therapy of prostatic carcinoma (author's transl)]. Keller AJ; Völter D; Bertsch H Urologe A; 1981 Jul; 20(4):228-30. PubMed ID: 7196633 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas. Stege R; Grande M; Carlström K; Tribukait B; Pousette A Clin Cancer Res; 2000 Jan; 6(1):160-5. PubMed ID: 10656445 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of prostatic cytology in primary diagnosis and clinical course of prostatic carcinoma. Bandhauer K; Spieler P; Egle N Prog Clin Biol Res; 1976; 6():329-45. PubMed ID: 1023215 [TBL] [Abstract][Full Text] [Related]
4. [Treatment and prognosis of prostate carcinoma. Actual standing (author's transl)]. Heising J; Allhoff E Z Hautkr; 1981 Jun; 56(11):705-14. PubMed ID: 6167082 [TBL] [Abstract][Full Text] [Related]
5. Fine needle aspiration biopsy for diagnosis and follow-up of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Andersson L; Hagmar B; Ljung BM; Skoog L Scand J Urol Nephrol Suppl; 1994; 162():43-9; discussion 115-27. PubMed ID: 7817160 [TBL] [Abstract][Full Text] [Related]
6. [Cytology in the diagnosis of prostatic cancer (author's transl)]. Benoit G; Boccon-Gibod L; Dalian G; Steg A Sem Hop; 1980 Apr 18-25; 56(15-16):771-3. PubMed ID: 6246614 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostics and therapy of the carcinoma of the prostate (author's transl)]. Schnorr D; Guddat HM; Neuser D; Correns HJ; Dörner G; Mau S Zentralbl Chir; 1979; 104(7):436-45. PubMed ID: 112805 [TBL] [Abstract][Full Text] [Related]
8. [Cytological monitoring of the therapy of conservatively treated prostate cancer. Classification and clinical significance]. Leistenschneider W; Nagel R Urologe A; 1983 May; 22(3):144-50. PubMed ID: 6683897 [TBL] [Abstract][Full Text] [Related]
9. Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Murphy GP; Busch C; Abrahamsson PA; Epstein JI; McNeal JE; Miller GJ; Mostofi FK; Nagle RB; Nordling S; Parkinson C Scand J Urol Nephrol Suppl; 1994; 162():7-42; discussion 115-27. PubMed ID: 7817162 [TBL] [Abstract][Full Text] [Related]
10. [Aspects for hormone therapy in prostate cancer]. Gorski J; Böhm WD; Kelly LU Z Urol Nephrol; 1981 Sep; 74(9):635-41. PubMed ID: 7314984 [TBL] [Abstract][Full Text] [Related]
11. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading]. Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974 [TBL] [Abstract][Full Text] [Related]
12. [Cytological diagnosis of prostatic cancer by transrectal aspiration biopsy (author's transl)]. Clavel E; Fontanière B; Guibert B; Faucon M Sem Hop; 1980 May 18-25; 56(19-20):972-8. PubMed ID: 6251562 [TBL] [Abstract][Full Text] [Related]
13. [Changes in the prostatic cancer cells caused by estrogen therapy--cytological study by aspiration biopsy]. Takeuchi H Gan No Rinsho; 1971; 17(9):692-9. PubMed ID: 5165863 [No Abstract] [Full Text] [Related]
14. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. King CR; McNeal JE; Gill H; Presti JC Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152 [TBL] [Abstract][Full Text] [Related]
15. [Morphological and clinical results after combined hormone and radiation therapy for carcinoma of the prostate (author's transl)]. Kastendieck H; Altenähr E; Burchardt P; Becker H; Franke HD; Klosterhalfen H Dtsch Med Wochenschr; 1976 Apr; 101(15):571-6. PubMed ID: 1261373 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients. Grande M; Carlström K; Rozell BL; Stege R; Pousette A Clin Cancer Res; 2000 May; 6(5):1790-5. PubMed ID: 10815899 [TBL] [Abstract][Full Text] [Related]
17. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800 [TBL] [Abstract][Full Text] [Related]
18. [The role of repeated biopsies in prognosis of prostate cancer]. Romics I; Lovász S; Szabó J; Szomor L; Minik K; Bartók K; Kerényi T; Szende B Orv Hetil; 2002 Jul; 143(27):1619-23. PubMed ID: 12179998 [TBL] [Abstract][Full Text] [Related]
19. The independent impact of extended pattern biopsy on prostate cancer stage migration. Master VA; Chi T; Simko JP; Weinberg V; Carroll PR J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288 [TBL] [Abstract][Full Text] [Related]
20. Prostatic carcinoma cured with hormonal treatment. A report of two cases. Johansson S; Ljunggren E Scand J Urol Nephrol; 1981; 15(3):321-2. PubMed ID: 7323757 [No Abstract] [Full Text] [Related] [Next] [New Search]